JAGSNPHARM trade ideas
Jagsonpal Pharma High Volume Breakout1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price)
4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors)
After a TTM sales and profit growth of 24% and 83% respectively, NSE:JAGSNPHARM gave a high-volume breakout on Friday. As the market condition is volatile, one should wait for a pullback in this stock up to Rs.179-Rs. 187 range and then buy if stock prices breaks out above Rs. 213 with a stop loss just below the pullback low. Aggressive investors can buy with a stop at or below Rs. 174.
Other Fundamentals: -
1. ROE at 15%, ROCE at 18%, Promoter holding at 70.3%
2. Current Ratio at 1.95 (greater than 1.5 is good), Debt to Equity at 0.06 (less than 0.5 is good and debt came down from 38 in 2016 to 7 in Sep'21), Interest Coverage at 97 (greater than 3 is good)
3. FCF to CFO at 122% (company won't need to borrow for capex in future)
4. Debtor days improved from 49 in Mar'20 to 25 in Mar'21
5. FII position increased From 0.11 to 0.20 since Sep'21
Only one negative for this company: - The company has entered into an agreement with Suvinys Developers Private Limited
for Supply of Product Dydrogesterone. Suvinys Developers Private Limited will supply Dydrogesterone to Jagsonpal Pharmaceuticals Limited. Directors of Suvinys Developers Private Limited, Rajpal Singh Kochhar is also the managing director of Jagsonpal Pharmaceuticals. This may be a Red Flag.
JAGSONPAL PHARMA - Bullish View As per Ichimoku Cloud RuleJAGSONPAL PHARMA is howing the strength. As per the ichimoiku rule, today's close is above the cloud and future kumo
is very much bullish and chikou span is slanting upwards. All these parameters are showing the further strength in JAGSONPAL PHARMA
More strength will be visible once it will cross 250 and it can create new high. Worth to keep in watch list for coming days
#This is not Buy and Sell recommendation to any one. This is for education purpose and a helping hand to learn trading in Market.
# Rule Based Investing
# Ichimoku Cloud
# Ichimoku Followers
I hope you all like my analysis. Please do share your thoughts into comment section of Trading View.
Please give a like, it motivates me to do analysis and do share our channel with your friends as well.
#JAGSNPHARM#JAGSNPHARM
CMP - 209.60
Can be looked in the range 180 to 186
OR
Above above 215
Next Levels can be expected 215, 265
View will be negated below 153
Disclaimer : We are not Sebi registered analyst or Authorized analyst
The charts / Levels / Price projections are only for educational purpose.
This is our personal view, Pls consult your financial advisor before taking decision - Buy / Sell
We will be not responsible for your profit and Loss
Please like and retweet if you like this idea.
With volume, With Price A Darvas BoxJagsonpal Pharmaceuticals is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. The Company has operations in India and caters to both domestic and international markets.
After its long-range bound it has moved above range with volume creating a Darvas box formation making its the time to enter